Craig E. Eckfeldt, MD, PhD received an Equipment Grant from the University of Minnesota Foundation to support the purchase of a fluorescent inverted microscope with an integrated digital imaging system. Dr. Eckfeldt and researchers at the Masonic Cancer Center will use the fluorescent microscope to study live cells that have been genetically modified to express fluorescent proteins or are stained with fluorescent dyes. These studies will allow for a better understanding of cancer genetics, cancer signaling, and tumor immunology, with the goal of identifying novel druggable targets and ways to harness the immune system for cancer treatment. The University of Minnesota Foundation Equipment Grant is meant to provide funds to purchase equipment that is truly needed for cutting-edge medical research at the University of Minnesota and that will be shared by a large group of collaborative investigators. 11/14/13
Congratulations to Carol Lange, Ph.D., Cell Signaling Program leader and director of the Cancer Biology Training Grant, on being named The Clinical and Translational Science Institute 2013 Mentor of the Year. The honor also included a $2,500 award. 10/18/13
Kalpna Gupta, PhD, along with a team of researchers from the University of Minnesota, was awarded a UO1 grant from the National Heart, Lung and Blood Institute to study the mechanisms, quantification, and therapy for pain in sickle cell disease (SCD). Patients with SCD suffer from debilitating pain that starts early in life, increases in severity with age, and is particularly difficult to treat. Opioid treatment remains a suboptimal approach because of serious side effects, including tolerance and addiction, that lead to high rates of morbidity and mortality.The multidisciplinary project brings together scientific experts from engineering, biology, neuroscience, hematology, and integrative medicine to study SCD-related pain and its treatment. Other principal investigators on the project include University of Minnesota researchers Bin He, PhD (Biomedical Engineering); Donald Simone, PhD (Diagnostic and Biological Sciences); and Robert Hebbel, MD (Medicine) and University of California at San Francisco researcher Donald Abrams, MD. Please join us in congratulating these researchers on receipt of this highly esteemed award of $9.5 million. 08/27/13
“This grant is important because it addresses a major cause for the suffering of sickle patients, many of whom are under-represented minorities” said Dr. Gupta, lead principal investigator of the project.
Daniel Weisdorf, MD
Dr. McGlave Recognition
Philip McGlave, MD elected to step away from his role as Director of the Division of Hematology, Oncology and Transplantation (HOT) after more than 15 years of leadership. (Read more...)
Click here to learn more about Faculty and Trainee Accomplishments